AMBALAL SARABHAI ENTERPRISES Financial Statement Analysis
|
||
|
The Revenues of AMBALAL SARABHAI ENTERPRISES have decreased by -13.45% YoY .
The Earnings Per Share (EPS) of AMBALAL SARABHAI ENTERPRISES has decreased by -50.34 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
AMBALAL SARABHAI ENTERPRISES Last 5 Annual Financial Results
[BOM: 500009|NSE : AMBASARABH]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹170 Cr | ₹197 Cr | ₹164 Cr | ₹133 Cr | ₹152 Cr |
| Expenses | ₹161 Cr | ₹172 Cr | ₹165 Cr | ₹135 Cr | ₹146 Cr |
| Operating Profit (Excl OI) | ₹8.84 Cr | ₹25 Cr | ₹-1.54 Cr | ₹-1.91 Cr | ₹5.89 Cr |
| Other Income | ₹12 Cr | ₹42 Cr | ₹31 Cr | ₹24 Cr | ₹5.47 Cr |
| Interest | ₹2.71 Cr | ₹2.04 Cr | ₹3.20 Cr | ₹3.61 Cr | ₹3.29 Cr |
| Depreciation | ₹2.76 Cr | ₹2.32 Cr | ₹2.41 Cr | ₹2.57 Cr | ₹2.10 Cr |
| Profit Before Tax | ₹15 Cr | ₹54 Cr | ₹33 Cr | ₹16 Cr | ₹5.97 Cr |
| Profit After Tax | ₹11 Cr | ₹47 Cr | ₹29 Cr | ₹15 Cr | ₹2.00 Cr |
| Consolidated Net Profit | ₹11 Cr | ₹47 Cr | ₹29 Cr | ₹14 Cr | ₹4.25 Cr |
| Earnings Per Share (Rs) | ₹0.74 | ₹1.49 | ₹6.16 | ₹3.83 | ₹1.83 |
| PAT Margin (%) | 3.16 | 6.53 | 23.39 | 17.57 | 11.17 |
| ROE(%) | 4.24 | 9.13 | 48.74 | 49.47 | 40.95 |
| ROCE(%) | 7.15 | 11.18 | 45.53 | 40.28 | 27.14 |
| Total Debt/Equity(x) | 0.33 | 0.33 | 0.21 | 0.37 | 0.70 |
Key Financials |
||
| Market Cap | : | ₹ 269.6 Cr |
| Revenue (TTM) | : | ₹ 185.7 Cr |
| Net Profit(TTM) | : | ₹ 14.5 Cr |
| EPS (TTM) | : | ₹ 1.9 |
| P/E (TTM) | : | 18.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AMBALAL SARABHAI ENTERPRISES | -4.1% | -7.6% | -21.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -4.9% | 2.1% | 15.5% |
| DIVIS LABORATORIES | -2.2% | 9.3% | 50.5% |
| CIPLA | -4.2% | 4.5% | 4.5% |
| TORRENT PHARMACEUTICALS | -4.4% | -4.5% | 17.2% |
| DR REDDYS LABORATORIES | -1.4% | 4.2% | -8.8% |
| MANKIND PHARMA | -0.1% | -1.5% | 6.6% |
| ZYDUS LIFESCIENCES | -1.6% | 1.3% | -14.6% |
| LUPIN | -2.4% | 3.4% | 19.9% |
AMBALAL SARABHAI ENTERPRISES Revenues
[BOM: 500009|NSE : AMBASARABH]
| Y-o-Y | -13.45 % |
| 5 Yr CAGR | 2.90 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹170 Cr | -13.45 | |
| Mar2023 | ₹197 Cr | 20.23 | |
| Mar2022 | ₹164 Cr | 22.58 | |
| Mar2021 | ₹133 Cr | -12.10 | |
| Mar2020 | ₹152 Cr | - | |
AMBALAL SARABHAI ENTERPRISES Operating Profit
[BOM: 500009|NSE : AMBASARABH]
| Y-o-Y | -64.96 % |
| 5 Yr CAGR | 10.71 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹8.84 Cr | -64.96 | |
| Mar2023 | ₹25 Cr | Positive | |
| Mar2022 | ₹-1.54 Cr | Negative | |
| Mar2021 | ₹-1.91 Cr | Negative | |
| Mar2020 | ₹5.89 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -59.52 % |
| 5 Yr CAGR | 7.61 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 5.19% | -59.52 | |
| Mar2023 | 12.82% | Positive | |
| Mar2022 | -0.94% | Negative | |
| Mar2021 | -1.43% | Negative | |
| Mar2020 | 3.87% | - | |
AMBALAL SARABHAI ENTERPRISES Profit After Tax
[BOM: 500009|NSE : AMBASARABH]
| Y-o-Y | -75.76 % |
| 5 Yr CAGR | 28.12 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹11 Cr | -75.76 | |
| Mar2023 | ₹47 Cr | 60.86 | |
| Mar2022 | ₹29 Cr | 108.75 | |
| Mar2021 | ₹14 Cr | 230.95 | |
| Mar2020 | ₹4.25 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -51.61 % |
| 5 Yr CAGR | -27.07 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 3.16 % | -51.61 | |
| Mar2023 | 6.53 % | -72.08 | |
| Mar2022 | 23.39 % | 33.12 | |
| Mar2021 | 17.57 % | 57.30 | |
| Mar2020 | 11.17 % | - | |
AMBALAL SARABHAI ENTERPRISES Earnings Per Share (EPS)
[BOM: 500009|NSE : AMBASARABH]
| Y-o-Y | -50.34 % |
| 5 Yr CAGR | -20.26 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.74 | -50.34 | |
| Mar2023 | ₹1.49 | -75.81 | |
| Mar2022 | ₹6.16 | 60.84 | |
| Mar2021 | ₹3.83 | 109.29 | |
| Mar2020 | ₹1.83 | - | |
AMBALAL SARABHAI ENTERPRISES Return on Capital Employed (ROCE)
[BOM: 500009|NSE : AMBASARABH]
| Y-o-Y | -36.05 % |
| 5 Yr CAGR | -28.36 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 7.15% | -36.05 | |
| Mar2023 | 11.18% | -75.44 | |
| Mar2022 | 45.53% | 13.03 | |
| Mar2021 | 40.28% | 48.42 | |
| Mar2020 | 27.14% | - | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Current Share Price | : | ₹35.2 |
| Current MarketCap | : | ₹ 269.6 Cr |
| Updated EOD on | : | May 09,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -4.1% |
-7.6% |
-21.2% |
| SENSEX | -1.3% |
4.1% |
7.6% |
AMBALAL SARABHAI ENTERPRISES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about AMBALAL SARABHAI ENTERPRISES Financials
How the annual revenues of AMBALAL SARABHAI ENTERPRISES have changed ?
The Revenues of AMBALAL SARABHAI ENTERPRISES have decreased by -13.45% YoY .
How the Earnings per Share (EPS) of AMBALAL SARABHAI ENTERPRISES have changed?
The Earnings Per Share (EPS) of AMBALAL SARABHAI ENTERPRISES has decreased by -50.34 % YoY .
Check out Intrinsic Value of Peers of AMBALAL SARABHAI ENTERPRISES
Compare Stock Analytics of Peers of AMBALAL SARABHAI ENTERPRISES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
